The Anti-inflammatory Drugs Market: By Indication (Rheumatoid Arthritis, Chronic Obstructive Pulmonary Disease (COPD), Multiple Sclerosis, Inflammatory Bowel Disease (IBD), Psoriatic Arthritis, Gout)By Drug Type (Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Biologics, Immune Selective Anti-Inflammatory Derivatives (ImSAIDs)), By Formulation (Oral, Parenteral, Topical) By Distribution Channel (Hospital Pharmacy, Clinics, Online Pharmacy, Retail Pharmacy)By Geography


Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

Anti-inflammatory drugs market is described by the nearness of driving players. The players in the market are to a great extent concentrating on the advancement of biologicals, which have less reactions and better adequacy. In spite of the fact that biologics are costly, their improved wellbeing and adequacy will enable sellers to get a bigger offer of the market once launched. The ascend in key partnerships by merchants is one of the most recent patterns that will pick up footing in the anti-inflammatory therapeutics market in the coming years. The anti-inflammatory therapeutics market is right now an expansion in the procurement of anti-inflammatory therapeutics by significant merchants. For example, one of the main player Pfizer as of late obtained Anacor Pharmaceuticals. This helped Pfizer pick up the business rights for Anacor Pharmaceuticals' crisaborole, a non-steroidal topical PDE-4 inhibitor with anti-inflammatory properties, which was endorsed by the US FDA. Anti-inflammatory alludes to the property of a substance or treatment that diminishes irritation or swelling. Anti-inflammatory drugs Market make up about the portion of analgesics, curing torment by decreasing aggravation instead of opioids, which influence the focal sensory system to square torment motioning to the brain. Anti-inflammatory drugs are utilized to treat joint inflammation, sprains, excruciating periods and other difficult conditions. The vast majority experience no difficulty taking these tablets. In any case, a few people create symptoms which can now and again be not kidding. Specifically - on the off chance that you have any cardiovascular (heart, stroke or vein) condition or certain gut conditions, or are elderly, these drugs are endorsed with alert and just where there are no choices and at the most minimal measurements and terms vital.

Anti Inflammatory Drugs Market Summary

Study Period


Base Year




Largest Market

North America

Fastest Growing Market

Asia Pacific
Market Dynamics

The worldwide anti-inflammatory market has been driven by variables, for example, expanding the immune system and respiratory diseases, new medications in pipeline and expanding the adoption of anti-inflammatory drugs. The interest for anti-inflammatory drugs has been expanding inferable from the rise of anti-inflammatory biologics that are more focused on, viable and with lesser symptoms when contrasted with traditional medications. Additionally, expanding familiarity with anti-inflammatory market therapeutics and alluring government activities in the Asia-Pacific and LAMEA area are relied upon to drive the market amid the investigation time frame. Factors such as symptoms of anti-inflammatory medications and patent expiry issues of blockbuster drugs, (for example, Remicade), are known to hinder the market development.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2016-2021) and forecast (2022-2028).
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies.
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market The report tracks recent innovations, key developments and startup’s details that are actively working in the market .
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario.
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market.

Anti Inflammatory Drugs Market Segmentation

By application
  • Rheumatoid Arthritis
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Multiple Sclerosis
  • Inflammatory Bowel Disease (IBD)
  • Psoriatic Arthritis
  • Gout
by Drug Class
  • Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
  • Corticosteroids
  • Biologics
  • Immune Selective Anti-Inflammatory Derivatives (ImSAIDs)
By formulations
  • Oral
  • Parenteral
  • Topical
By End User
  • Hospital Pharmacy
  • Clinics
  • Online Pharmacy
  • Retail Pharmacy

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

  • Allergan, Inc. (S.)
  • AbbVie Inc., (U.S.)
  • Takeda Pharmaceutical Company Limited (Japan)
  • Bayer AG (Switzerland)
  • Pfizer Inc. (US)
  • Reddys (India)
  • Novartis (Switzerland)
  • Sanofi Avemtis (France)
  • Eli Lilly (US)